Literature DB >> 2282627

The serotonin hypothesis of bulimia nervosa: theory and evidence.

D S Goldbloom1, P E Garfinkel.   

Abstract

Bulimia nervosa is an eating disorder with multiple causes that has been the object of extensive research since it was first described in 1979. This review evaluates both the theoretical rationale and empirical evidence for a model which suggests that disturbed serotonin activity is involved in the development of this disorder. Limitations of the hypothesis and prospects for the future are considered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2282627     DOI: 10.1177/070674379003500904

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  6 in total

Review 1.  Current perspectives on drug therapies for anorexia nervosa and bulimia nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

2.  Advances in the Treatment of Anorexia Nervosa and Bulimia Nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

Review 3.  Factors that may influence future approaches to the eating disorders.

Authors:  P E Garfinkel; B J Dorian
Journal:  Eat Weight Disord       Date:  1997-03       Impact factor: 4.652

4.  Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa.

Authors:  S H Kennedy; B A Davis; G M Brown; C G Ford; J d'Souza
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

Review 5.  Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities.

Authors:  J L Jarry; F J Vaccarino
Journal:  J Psychiatry Neurosci       Date:  1996-01       Impact factor: 6.186

6.  Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behavior and mood rating scores in brofaromine-treated women with bulimia nervosa.

Authors:  B A Davis; S H Kennedy; J D'Souza; D A Durden; D S Goldbloom; A A Boulton
Journal:  J Psychiatry Neurosci       Date:  1994-07       Impact factor: 6.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.